Revenue
attach_money0M USD
-
NAMSWNewAmsterdam Pharma Company N.V.$ --
NewAmsterdam Pharma Company N.V.
NAMSW
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-66M USD
-
Net Income
verified-75M USD
-
EPS
paid-0.65$
-
Revenue
$32,000
BEAT
$1.6M
$3M
$3.5M
$19.1M
$5.3M
$348,000
$1.3M
$32,000
$11.6M
$22.5M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Net Income
$-74.9M
BEAT
$-58.3M
$-39.5M
$-54.9M
$-17.4M
$-46.3M
$-72M
$-66.3M
$-74.9M
$-225.7M
$-203.8M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Surprise History
ActualEstimate
FY2025MISS